Compare ANIP & GT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ANIP | GT |
|---|---|---|
| Founded | 2001 | 1898 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Automotive Aftermarket |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 2.0B |
| IPO Year | N/A | N/A |
| Metric | ANIP | GT |
|---|---|---|
| Price | $80.93 | $9.47 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 6 | 5 |
| Target Price | ★ $107.33 | $10.36 |
| AVG Volume (30 Days) | 532.5K | ★ 5.6M |
| Earning Date | 02-27-2026 | 02-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 1.67 | N/A |
| Revenue | $826,880,000.00 | ★ $18,310,000,000.00 |
| Revenue This Year | $44.35 | N/A |
| Revenue Next Year | $11.13 | $0.86 |
| P/E Ratio | $48.56 | ★ N/A |
| Revenue Growth | ★ 48.87 | N/A |
| 52 Week Low | $54.10 | $6.51 |
| 52 Week High | $99.50 | $12.03 |
| Indicator | ANIP | GT |
|---|---|---|
| Relative Strength Index (RSI) | 43.98 | 59.58 |
| Support Level | $83.03 | $9.43 |
| Resistance Level | $86.97 | $9.68 |
| Average True Range (ATR) | 3.53 | 0.27 |
| MACD | -0.03 | 0.02 |
| Stochastic Oscillator | 42.98 | 73.05 |
ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid-dose products. Its areas of product development include narcotics, oncolytics, hormones and steroids, and complex formulations involving extended-release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. The company operates in two segments which include Rare Diseases and Brands, Generics, and Others. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.
Goodyear Tire & Rubber Co manufactures and sells a variety of rubber tires under the Goodyear brand name. The firm's tires are used for automobiles, trucks, buses, aircraft, motorcycles, mining equipment, farm equipment, and industrial equipment. The company operates its business through three operating segments representing its regional tire businesses: Americas; Europe, the Middle East, and Africa (EMEA); and the Asia Pacific.